Voyager Therapeutics Inc (MEX:VYGR)
MXN 165 0 (0%) Market Cap: 7.30 Bil Enterprise Value: 776.10 Mil PE Ratio: 30.23 PB Ratio: 1.08 GF Score: 71/100

Q4 2019 Voyager Therapeutics Inc Earnings Call Transcript

Mar 03, 2020 / 09:30PM GMT
Release Date Price: MXN286.78
Operator

Good afternoon, and welcome to the Voyager Therapeutics Fourth Quarter and Full Year 2019 Financial Results Conference Call. (Operator Instructions) This call is being webcast live on the Investor and Media section of Voyager's website at voyagertherapeutics.com. This call is the property of Voyager Therapeutics and recordings, reproduction or transmission of this call without the expressed written consent of Voyager Therapeutics is strictly prohibited. Please be advised that this call is being recorded.

I would now like to introduce Paul Cox, Head of Investor Relations at Voyager.

Paul Cox
Voyager Therapeutics, Inc. - VP of IR

Good afternoon, and thank you for joining us. With me on the call today are Andre Turenne, our President and Chief Executive Officer; Omar Khwaja, Chief Medical Officer and Head of R&D; and Allison Dorval, Chief Financial Officer. This afternoon, after market close, we issued a press release, which outlines the financial results and corporate highlights for the fourth quarter and full year 2019. The release is available at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot